Literature DB >> 19664747

A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions.

Henna Tyynismaa1, Emil Ylikallio, Mehul Patel, Maria J Molnar, Ronald G Haller, Anu Suomalainen.   

Abstract

Autosomal-dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder that is characterized by accumulation of multiple mitochondrial DNA (mtDNA) deletions in postmitotic tissues. The disorder is heterogeneous, with five known nuclear disease genes that encode the proteins ANT1, Twinkle, POLG, POLG2, and OPA1. Defects in these proteins affect mtDNA maintenance, probably leading to stalled replication forks, consequent mtDNA deletion formation, and progressive respiratory chain deficiency. Here we present a large adPEO family with multiple mtDNA deletions, whose disease was not explained by mutations in any of the known adPEO loci. We mapped the disease locus in this family to chromosome 8q22.1-q23.3. The critical linkage region contained the RRM2B gene, which encodes the small subunit of the ribonucleotide reductase p53R2, which has previously been shown to be essential for the maintenance of mtDNA copy number. Mutation screening of RRM2B revealed a heterozygous nonsense mutation in exon 9 (c.979C-->T [p.R327X]) in all affected individuals that was absent in 380 control chromosomes. The same mutation was found to segregate in another adPEO family. The mutant mRNA escaped nonsense-mediated decay and resulted in a protein with truncation of 25 highly conserved C-terminal amino acids essential for the interaction with the ribonucleotide reductase subunit R1. We conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664747      PMCID: PMC2725268          DOI: 10.1016/j.ajhg.2009.07.009

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  39 in total

Review 1.  Ribonucleotide reductases.

Authors:  Pär Nordlund; Peter Reichard
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.

Authors:  Pelle Håkansson; Anders Hofer; Lars Thelander
Journal:  J Biol Chem       Date:  2006-01-24       Impact factor: 5.157

3.  Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion.

Authors:  Emmanuelle Sarzi; Steffi Goffart; Valérie Serre; Dominique Chrétien; Abdelhamid Slama; Arnold Munnich; Johannes N Spelbrink; Agnès Rötig
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

Review 4.  DNA precursor metabolism and genomic stability.

Authors:  Christopher K Mathews
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

5.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.

Authors:  Alice Bourdon; Limor Minai; Valérie Serre; Jean-Philippe Jais; Emmanuelle Sarzi; Sophie Aubert; Dominique Chrétien; Pascale de Lonlay; Véronique Paquis-Flucklinger; Hirofumi Arakawa; Yusuke Nakamura; Arnold Munnich; Agnès Rötig
Journal:  Nat Genet       Date:  2007-05-07       Impact factor: 38.330

6.  Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion.

Authors:  Anna H Hakonen; Pirjo Isohanni; Anders Paetau; Riitta Herva; Anu Suomalainen; Tuula Lönnqvist
Journal:  Brain       Date:  2007-10-05       Impact factor: 13.501

7.  Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene.

Authors:  Belén Bornstein; Estela Area; Kevin M Flanigan; Jaya Ganesh; Parul Jayakar; Kathryn J Swoboda; Jorida Coku; Ali Naini; Sara Shanske; Kurenai Tanji; Michio Hirano; Salvatore DiMauro
Journal:  Neuromuscul Disord       Date:  2008-05-27       Impact factor: 4.296

8.  Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy.

Authors:  Luigi Palmieri; Simona Alberio; Isabella Pisano; Tiziana Lodi; Mija Meznaric-Petrusa; Janez Zidar; Antonella Santoro; Pasquale Scarcia; Flavia Fontanesi; Eleonora Lamantea; Iliana Ferrero; Massimo Zeviani
Journal:  Hum Mol Genet       Date:  2005-09-09       Impact factor: 6.150

9.  Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.

Authors:  Gavin Hudson; Patrizia Amati-Bonneau; Emma L Blakely; Joanna D Stewart; Langping He; Andrew M Schaefer; Philip G Griffiths; Kati Ahlqvist; Anu Suomalainen; Pascal Reynier; Robert McFarland; Douglass M Turnbull; Patrick F Chinnery; Robert W Taylor
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

10.  p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage.

Authors:  Giovanna Pontarin; Paola Ferraro; Pelle Håkansson; Lars Thelander; Peter Reichard; Vera Bianchi
Journal:  J Biol Chem       Date:  2007-04-07       Impact factor: 5.157

View more
  41 in total

1.  Response to Letter to the Editor: Can MR spectroscopy and muscle biopsy findings be correlated in MELAS and CPEO?

Authors:  Feng-Nan Niu; Hai-Lan Meng; Ren-Yuan Liu; Bing Zhang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-10       Impact factor: 5.243

Review 2.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

3.  A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions.

Authors:  Esther Leshinsky-Silver; Gustavo Malinger; Liat Ben-Sira; Dvora Kidron; Sarit Cohen; Shani Inbar; Tali Bezaleli; Arie Levine; Chana Vinkler; Dorit Lev; Tally Lerman-Sagie
Journal:  Eur J Hum Genet       Date:  2010-11-24       Impact factor: 4.246

4.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.

Authors:  Sha Tang; Elliot L Dimberg; Margherita Milone; Lee-Jun C Wong
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

Review 5.  Defects in mitochondrial DNA replication and human disease.

Authors:  William C Copeland
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 Jan-Feb       Impact factor: 8.250

Review 6.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells.

Authors:  Giovanna Pontarin; Paola Ferraro; Leonardo Bee; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint.

Authors:  Dinesh Kumar; Jörgen Viberg; Anna Karin Nilsson; Andrei Chabes
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

10.  Mitochondrial DNA abnormalities in ophthalmological disease.

Authors:  Grainne S Gorman; Robert W Taylor
Journal:  Saudi J Ophthalmol       Date:  2011-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.